HeartSciences
HSCS

HeartSciences (HSCS) earnings history

Most recent quarter

Period end
Oct 31, 2025
EPS actual
−$0.85
EPS estimate
−$0.77
EPS surprise
−10.39%
Revenue
$0.00
Reported
Dec 15, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2026Dec 15, 2025−$0.77−$0.85−10.39%$0.00SEC
Q1 2026Sep 11, 2025−$1.88−$1.51+19.47%$0.00SEC
Q4 2025Jul 24, 2025−$1.78−$1.91−7.30%$0.00SEC
Q3 2025Mar 13, 2025−$2.31−$2.55−10.41%$0.00SEC
Q2 2025Dec 16, 2024−$2.34−$2.27+2.78%$0.00SEC
Q1 2025Sep 12, 2024−$2.31−$2.61−13.02%$0.00SEC
Q4 2024Jul 29, 2024−$3.50−$2.90+17.14%$0.00SEC
Q3 2024Mar 14, 2024−$6.00−$3.00+50.00%$14,700.00SEC
Q2 2024Dec 14, 2023−$12.00−$16.00−33.33%$3,900.00SEC
Q1 2024Sep 14, 2023−$14.00−$13.00+7.14%$0.00SEC
Q4 2023Jul 19, 2023−$16.00−$17.00−6.25%$0.00SEC

Quarterly revenue

Q4 2023
$0.00
Q1 2024
$0.00
Q2 2024
$3,900.00
Q3 2024
$14,700.00
Q4 2024
$0.00
Q1 2025
$0.00
Q2 2025
$0.00
Q3 2025
$0.00
Q4 2025
$0.00
Q1 2026
$0.00
Q2 2026
$0.00

Frequently asked questions

  • When did HeartSciences (HSCS) last report earnings?

    HeartSciences last reported on Dec 15, 2025, covering fiscal Q2 2026.

  • Did HSCS beat earnings estimates?

    No. HeartSciences reported EPS of −$0.85 for Q2 2026 against a −$0.77 estimate — a 10.39% miss.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.